Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 1
Results: 24
Reviewer Lists.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 214, doi. 10.1093/neuonc/noac277
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 217, doi. 10.1093/neuonc/noac259
- Publication type:
- Article
Erratum to: Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
road we travel.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 135, doi. 10.1093/neuonc/noac235
- By:
- Publication type:
- Article
Optimize treatment approaches in isocitrate dehydrogenase (IDH) mutant gliomas: open issues.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 26, doi. 10.1093/neuonc/noac227
- By:
- Publication type:
- Article
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 123, doi. 10.1093/neuonc/noac099
- By:
- Publication type:
- Article
Negative trials over and over again: How can we do better?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 1, doi. 10.1093/neuonc/noac226
- By:
- Publication type:
- Article
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 28, doi. 10.1093/neuonc/noac205
- By:
- Publication type:
- Article
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 137, doi. 10.1093/neuonc/noac137
- By:
- Publication type:
- Article
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 157, doi. 10.1093/neuonc/noac144
- By:
- Publication type:
- Article
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 199, doi. 10.1093/neuonc/noac132
- By:
- Publication type:
- Article
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 4, doi. 10.1093/neuonc/noac207
- By:
- Publication type:
- Article
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 37, doi. 10.1093/neuonc/noac196
- By:
- Publication type:
- Article
Recovery from the damage of cranial radiation modulated by memantine, an NMDA receptor antagonist, combined with hyperbaric oxygen therapy.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 108, doi. 10.1093/neuonc/noac162
- By:
- Publication type:
- Article
Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 97, doi. 10.1093/neuonc/noac158
- By:
- Publication type:
- Article
Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 82, doi. 10.1093/neuonc/noac157
- By:
- Publication type:
- Article
Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 68, doi. 10.1093/neuonc/noac154
- By:
- Publication type:
- Article
Diversity within the neurosurgical oncology workforce in the United States: A cross-sectional study with proposed strategies to pave the path forward.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 177, doi. 10.1093/neuonc/noac150
- By:
- Publication type:
- Article
Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 167, doi. 10.1093/neuonc/noac148
- By:
- Publication type:
- Article
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 185, doi. 10.1093/neuonc/noac147
- By:
- Publication type:
- Article
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 54, doi. 10.1093/neuonc/noac141
- By:
- Publication type:
- Article
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 146, doi. 10.1093/neuonc/noac139
- By:
- Publication type:
- Article